Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara A Goff

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Gynecologic Oncology|November 3, 2011
Involvement in decision-making about treatment and ovarian cancer survivor quality of lifeM Robyn Andersen, Erin Sweet, Kimberly A Lowe, et al.
American Journal of Obstetrics and Gynecology|June 21, 2020
Reengineering academic departments of obstetrics and gynecology to operate in a pandemic world and beyond: a joint American Gynecological and Obstetrical Society and Council of University Chairs of Obstetrics and Gynecology statementRonald D Alvarez, Barbara A Goff, David Chelmow, et al.
Gynecologic Oncology|November 9, 2011
Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptabilityBarbara A Goff, Kimberly A Lowe, Jeannette C Kane, et al.
Journal of Women'S Health (2002)|February 17, 2010
Identification of ovarian cancer symptoms in health insurance claims dataSean M Devlin, Paula H Diehr, M Robyn Andersen, et al.
American Journal of Obstetrics and Gynecology|October 17, 2015
Route of hysterectomy and surgical outcomes from a statewide gynecologic oncology population: is there a role for vaginal hysterectomy?Tiffany L Beck, Christopher B Morse, Heidi J Gray, et al.
Gynecologic Oncology|April 20, 2010
Ovarian cancer in the elderly: outcomes with neoadjuvant chemotherapy or primary cytoreductionKate A McLean, Chirag A Shah, Sara A Thompson, et al.
Gynecologic Oncology|May 2, 2013
Recurrence patterns after extended treatment with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancersMinh D Dao, Laura M Alwan, Heidi J Gray, et al.
Gynecologic Oncology|September 28, 2011
Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancerMelissa M Thrall, Heidi J Gray, Rebecca Gaston Symons, et al.
American Journal of Preventive Medicine|August 18, 2012
Nonrecommended breast and colorectal cancer screening for young women: a vignette-based surveyHajar Kadivar, Barbara A Goff, William R Phillips, et al.
Gynecologic Oncology|March 4, 2008
Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancerChirag A Shah, Kimberly H Allison, Rochelle L Garcia, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Gynecologic Oncology|November 3, 2011
Involvement in decision-making about treatment and ovarian cancer survivor quality of lifeM Robyn Andersen, Erin Sweet, Kimberly A Lowe, et al.
American Journal of Obstetrics and Gynecology|June 21, 2020
Reengineering academic departments of obstetrics and gynecology to operate in a pandemic world and beyond: a joint American Gynecological and Obstetrical Society and Council of University Chairs of Obstetrics and Gynecology statementRonald D Alvarez, Barbara A Goff, David Chelmow, et al.
Gynecologic Oncology|November 9, 2011
Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptabilityBarbara A Goff, Kimberly A Lowe, Jeannette C Kane, et al.
Journal of Women'S Health (2002)|February 17, 2010
Identification of ovarian cancer symptoms in health insurance claims dataSean M Devlin, Paula H Diehr, M Robyn Andersen, et al.
American Journal of Obstetrics and Gynecology|October 17, 2015
Route of hysterectomy and surgical outcomes from a statewide gynecologic oncology population: is there a role for vaginal hysterectomy?Tiffany L Beck, Christopher B Morse, Heidi J Gray, et al.
Gynecologic Oncology|April 20, 2010
Ovarian cancer in the elderly: outcomes with neoadjuvant chemotherapy or primary cytoreductionKate A McLean, Chirag A Shah, Sara A Thompson, et al.
Gynecologic Oncology|May 2, 2013
Recurrence patterns after extended treatment with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancersMinh D Dao, Laura M Alwan, Heidi J Gray, et al.
Gynecologic Oncology|September 28, 2011
Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancerMelissa M Thrall, Heidi J Gray, Rebecca Gaston Symons, et al.
American Journal of Preventive Medicine|August 18, 2012
Nonrecommended breast and colorectal cancer screening for young women: a vignette-based surveyHajar Kadivar, Barbara A Goff, William R Phillips, et al.
Gynecologic Oncology|March 4, 2008
Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancerChirag A Shah, Kimberly H Allison, Rochelle L Garcia, et al.
Pageof 13